OPC Pharmaceutical JSC

OPC Pharmaceutical JSC FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of OPC Pharmaceutical JSC (OPC.VN) as of Nov 4, 2026 is 13.35 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -46.13 % — a change of -128.94% (higher).

FCF Conversion

13.35 %

YoY

-128.94%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of OPC Pharmaceutical JSC is 2024 13.35 % . FCF Conversion Rate (FCF/EBITDA) of OPC Pharmaceutical JSC was 2023 -46.13 % . It decreases by -128.94% higher compared to the previous year.

The OPC Pharmaceutical JSC FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2014
114.14 VND
Jan 1, 2015
92.74 VND
Jan 1, 2016
130.63 VND
Jan 1, 2017
-172.50 VND
Jan 1, 2018
-46.13 VND
Jan 1, 2024
13.35 VND
The OPC Pharmaceutical JSC FCF Conversion history
YEARFCF ConversionYoY
13.35 %-128.94%
-46.13 %-73.26%
-172.50 %-232.05%
130.63 %+40.86%
92.74 %-18.75%
114.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OPC Pharmaceutical JSC Stock analysis

What does OPC Pharmaceutical JSC do? OPC Pharmaceutical JSC manufactures and markets pharmaceutical products derived from natural materials cultivated and processed at its facilities. The company produces and trades pharmaceutical chemicals and supplies, functional food, wine, and bottled water. Its primary revenue streams include the sale of manufactured drugs, pharmaceutical chemicals, and functional food to healthcare providers and consumers. The company also engages in wholesale trading of pharmaceutical products and supplies. OPC Pharmaceutical JSC's product portfolio includes drugs made from natural pharmaceutical materials, pharmaceutical chemicals, functional food, wine, and bottled water. The company markets these products through its own distribution channels, targeting both medical institutions and end consumers. The firm's operations in wine distillery and bottled water manufacturing complement its pharmaceutical business, providing additional revenue streams. The company's manufacturing and marketing activities focus on natural pharmaceutical materials, pharmaceutical chemicals, and functional food. Its sales are directed towards healthcare providers for drug distribution and to consumers for functional food, wine, and bottled water. The dissolution of OPC EXIM Real Estate Joint Stock Company in 2014 does not affect its core pharmaceutical and related product lines. OPC Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OPC Pharmaceutical JSC stock

FCF Conversion Rate (FCF/EBITDA) of OPC Pharmaceutical JSC is 13.35 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of OPC Pharmaceutical JSC changed from -46.13 % to 13.35 %, representing a -128.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) OPC Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s OPC Pharmaceutical JSC with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — OPC Pharmaceutical JSC

All Key Metrics — OPC Pharmaceutical JSC